Maxime Cordonnier
Director of Finance/CFO chez AFYREN
Provenance du réseau au premier degré de Maxime Cordonnier
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Imperial College London
56
| College/University | Other Consumer Services | 56 |
École Centrale Paris
17
| College/University | Other Consumer Services | 17 |
14
| Public Company | Biotechnology | 14 |
Yposkesi
 Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The private company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021.
3
| Subsidiary | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Maxime Cordonnier via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Harding Loevner LP
 Harding Loevner LP Investment ManagersFinance Harding Loevner LP is a SEC-registered investment advisor headquartered in Bridgewater, New Jersey. The firm was founded in 1989 by former managers for the Rockefeller family. They are a direct subsidiary of Titan NJ LP Holdings LLC, which is owned by Affiliated Managers Group, Inc. (NYSE: AMG). Harding Loevner provides investment management services to a variety of types of clients in the US such as retirement plans, foundations and endowments, sovereign wealth funds, religious institutions, individuals, trusts, broker-dealers, banks, investment advisers, insurance companies, mutual funds, collective investment trust funds, and offshore funds. | Investment Managers | Analyst-Equity Analyst-Equity | |
| SINOFORTUNE FINANCIAL HOLDINGS LIMITED | Specialty Stores | Chief Executive Officer Director/Board Member | |
| LUXKING GROUP HOLDINGS LIMITED | Industrial Specialties | Director/Board Member | |
| GECINA | Real Estate Investment Trusts | Chief Executive Officer | |
| KLÉPIERRE | Real Estate Development | Chief Operating Officer | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Other | Director/Board Member | |
Steen & Strøm AS
 Steen & Strøm AS Real Estate DevelopmentFinance Steen & Strøm AS owns, develops, and operates shopping centers. It manages shopping centers in Scandinavia, which includes Norway, Sweden and Denmark. The company was founded in 1797 and is headquartered in Oslo, Norway. | Real Estate Development | Director/Board Member | |
| ORPEA | Hospital/Nursing Management | Director/Board Member | |
| RENCO HOLDINGS GROUP LIMITED | Electronic Components | Director/Board Member | |
| EPC GROUPE | Chemicals: Specialty | Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Leeds | College/University | Undergraduate Degree Graduate Degree | |
| AKMERKEZ GAYRIMENKUL YATIRIM ORTAKLIGI | Real Estate Investment Trusts | Director/Board Member | |
Nomura International (Hong Kong) Ltd.
 Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Investment Banks/Brokers | Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree | |
| London Business School | College/University | Undergraduate Degree Masters Business Admin | |
| Bayes Business School | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of Florence | College/University | Graduate Degree | |
| King's College London | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Bain Capital Ltd.
 Bain Capital Ltd. Investment ManagersFinance Bain Capital LLC is one of the world's leading private investment firms managing approximately $66 billion in assets under management. Their affiliated advisors make private equity, public equity, leveraged debt asset, venture capital, and absolute return investments across multiple sectors, industries, and asset classes. Since their inception, their competitive advantage has been grounded in a people-intensive, value-added investment approach that has enabled the firm to deliver industry-leading returns for their investors. | Investment Managers | Private Equity Investor | |
| ANEVIA | Packaged Software | Founder Founder | |
| Grenoble Ecole de Management | College/University | Graduate Degree | |
Saipem SA
 Saipem SA Engineering & ConstructionIndustrial Services Saipem SA operates as an engineering and construction company. The company was founded in 1974 and is headquartered in Montigny-le-Bretonneux, France. | Engineering & Construction | Director/Board Member | |
European Public Real Estate Association
 European Public Real Estate Association Real Estate DevelopmentFinance European Public Real Estate Association provides interest for public real estate sectors. It specializes in investment research, listed real estate, index management, formulation of best practices recommendations, representation to the EU and regulatory bodies and networking for sector. The company was founded in October 1999 and is headquartered in Brussels, Belgium. | Real Estate Development | Director/Board Member | |
| City University London | College/University | Graduate Degree Graduate Degree | |
| Soochow Securities International Financial Holidings Ltd | Corporate Officer/Principal | ||
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Centrient Pharmaceuticals Netherlands BV
 Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Centrient Pharmaceuticals Netherlands BV produces green beta-lactams antibiotics. It offers active pharmaceutical ingredients and drug products for anti-infectives such as antibiotics, anti-fungals and other therapeutic classes like cholesterol lowering medicines. The company was founded in 1869 and is headquartered in Delft, the Netherlands. | Biotechnology | Director/Board Member | |
Bain Capital Private Equity (Europe) LLP
 Bain Capital Private Equity (Europe) LLP Investment ManagersFinance Bain Capital Private Equity (Europe) LLP engages in the provision of investment advisory services. The company was founded on November 12, 2012 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
| JOINN LABORATORIES(CHINA)CO.,LTD. | Biotechnology | Director/Board Member | |
Carmila France SAS
 Carmila France SAS Food RetailRetail Trade Carmila France SAS operates supermarkets and shopping galleries. It offers business and marketing solutions. The company was founded on April 16, 2014 and is headquartered in Paris, France. | Food Retail | Director/Board Member | |
Espace Expansion SAS
 Espace Expansion SAS Real Estate DevelopmentFinance Espace Expansion SAS is a French company that specializes in the administration of buildings and real estate properties. The private company is based in Paris, France. The CEO of the company is Olivier Bossard. | Real Estate Development | Chairman | |
Zhongtai International Capital Ltd.
 Zhongtai International Capital Ltd. Investment Banks/BrokersFinance Zhongtai International Capital Ltd. provides brokerage services and is ultimately controlled by the Province of Shandong. The private company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Corporate Officer/Principal | |
WI Harper Fund VIII LP
 WI Harper Fund VIII LP Investment ManagersFinance WI Harper Fund VIII LP seeks investment opportunities in companies located in the US and China. The fund targets companies operating in the fields of technology, clean technology and healthcare services. It provides financing for early growth and expansion stage capital requirements with an investment size ranging from $5 to $15 million. | Investment Managers | Corporate Officer/Principal | |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
CentraleSupélec Exed SA
 CentraleSupélec Exed SA Other Consumer ServicesConsumer Services CentraleSupélec operates as a higher education and research institution. The firm is a public institution under ministerial charter, devoted to the sciences and engineering. The company was founded on January 1, 2015 and is headquartered in Paris, France. | College/University | Director/Board Member Undergraduate Degree | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| LAPCO HOLDINGS LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
| CARMILA | Discount Stores | Director/Board Member | |
| Speechless Financial Technology Co. Ltd. | Founder | ||
Paris & Co.
 Paris & Co. Miscellaneous Commercial ServicesCommercial Services Paris & Co. operates as an economic development and innovation agency. The private company is based in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Centrient Holding BV
 Centrient Holding BV Finance/Rental/LeasingFinance Centrient Holding BV operates as a special purpose entity. The private company is based in Rotterdam, Netherlands. and has subsidiaries in Netherlands. The Dutch company was founded in 1869. Rex Clements has been the CEO of the company since 2020. | Finance/Rental/Leasing | Director/Board Member | |
Afyren Neoxy SAS
 Afyren Neoxy SAS Miscellaneous Commercial ServicesCommercial Services Afyren Neoxy SAS engages in the operation of a biotechnological company for the valorisation of non-food biomass into bioenergy. It offers 7 organic acids. The company was founded on August 09, 2018 and is headquartered in Saint-Beauzire, France. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| Ingénieurs De L'Ecole Centrale Des Arts Et Manufactures SA | Director/Board Member | ||
| Le Laboratoire Paris Region Innovation | Chairman | ||
| Afyren Investment SAS | Chairman | ||
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Founder |
Statistiques
Internationale
| France | 19 |
| Royaume-Uni | 13 |
| Hong Kong | 6 |
| Etats-Unis | 4 |
| Îles Cayman | 4 |
Sectorielle
| Finance | 15 |
| Consumer Services | 12 |
| Health Technology | 8 |
| Retail Trade | 4 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 157 |
| Corporate Officer/Principal | 123 |
| Undergraduate Degree | 62 |
| Graduate Degree | 52 |
| Private Equity Investor | 38 |
Relations les plus connectées
| Insiders | |
|---|---|
| Greg Hawkins | 26 |
| Adriano de Maio | 23 |
| Stefan Borgas | 22 |
| Imran Hamid | 14 |
| Thomas Railhac | 13 |
| Barbod Asisi Namini | 12 |
| Michael Krel | 11 |
| Olivier Mussat | 10 |
| Siew Moh Wong | 10 |
| Olivier Lecomte | 10 |
| André Puong | 10 |
| Kingsley Leung | 10 |
| Kwok Kei Mak | 9 |
| Claudio Albanese | 8 |
| Daniel Gotthardt | 8 |
- Bourse
- Insiders
- Maxime Cordonnier
- Connexions Sociétés
